Jian Ding

16.3k total citations
430 papers, 12.6k citations indexed

About

Jian Ding is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jian Ding has authored 430 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 294 papers in Molecular Biology, 137 papers in Oncology and 53 papers in Organic Chemistry. Recurrent topics in Jian Ding's work include Cancer therapeutics and mechanisms (59 papers), PI3K/AKT/mTOR signaling in cancer (40 papers) and Lung Cancer Treatments and Mutations (32 papers). Jian Ding is often cited by papers focused on Cancer therapeutics and mechanisms (59 papers), PI3K/AKT/mTOR signaling in cancer (40 papers) and Lung Cancer Treatments and Mutations (32 papers). Jian Ding collaborates with scholars based in China, United States and Ireland. Jian Ding's co-authors include Meiyu Geng, Liping Lin, Ze‐Hong Miao, Linghua Meng, Jian‐Min Yue, Min Huang, Linjiang Tong, Yi Chen, Xiongwen Zhang and Hua Xie and has published in prestigious journals such as Cell, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Jian Ding

417 papers receiving 12.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Ding China 54 7.8k 2.8k 2.6k 1.3k 916 430 12.6k
Muthu K. Shanmugam Singapore 62 6.7k 0.9× 2.5k 0.9× 1.0k 0.4× 2.0k 1.5× 487 0.5× 106 11.7k
Stefan Laufer Germany 62 6.8k 0.9× 1.8k 0.6× 4.0k 1.5× 801 0.6× 948 1.0× 469 15.2k
Aamir Ahmad United States 66 7.8k 1.0× 3.8k 1.4× 1.3k 0.5× 3.9k 3.0× 969 1.1× 254 13.8k
Qidong You China 55 8.4k 1.1× 1.9k 0.7× 2.9k 1.1× 1.2k 0.9× 424 0.5× 473 13.1k
Guang Liang China 57 5.6k 0.7× 1.1k 0.4× 1.6k 0.6× 1.2k 0.9× 777 0.8× 386 11.3k
Meiyu Geng China 48 5.3k 0.7× 1.4k 0.5× 1.6k 0.6× 1.1k 0.9× 597 0.7× 295 8.7k
Qiaojun He China 59 6.4k 0.8× 2.5k 0.9× 1.2k 0.5× 1.8k 1.4× 1.4k 1.5× 415 12.0k
Jin‐Jian Lu Macao 55 5.6k 0.7× 1.3k 0.5× 803 0.3× 911 0.7× 667 0.7× 237 9.8k
Sanjeev Banerjee United States 57 6.8k 0.9× 3.4k 1.2× 667 0.3× 2.8k 2.2× 601 0.7× 106 11.0k
Róbert Kiss Belgium 74 8.8k 1.1× 2.7k 1.0× 3.2k 1.3× 1.6k 1.2× 1.0k 1.1× 478 17.8k

Countries citing papers authored by Jian Ding

Since Specialization
Citations

This map shows the geographic impact of Jian Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Ding more than expected).

Fields of papers citing papers by Jian Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Ding. The network helps show where Jian Ding may publish in the future.

Co-authorship network of co-authors of Jian Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Ding. A scholar is included among the top collaborators of Jian Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Ding. Jian Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jia, Yan Yuan, Shengtao Yuan, et al.. (2024). Lasiokaurin Regulates PLK1 to Induce Breast Cancer Cell G2/M Phase Block and Apoptosis. Journal of Cancer. 15(8). 2318–2328. 3 indexed citations
3.
Wang, Xiyuan, Zhen Wang, Yan Zhang, et al.. (2024). Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect. SHILAP Revista de lepidopterología. 6(1). e70001–e70001. 6 indexed citations
4.
Zhang, Xiaoyi, Tong Zhao, Minghao Sun, et al.. (2023). Design, synthesis and biological evaluation of KRASG12C-PROTACs. Bioorganic & Medicinal Chemistry. 78. 117153–117153. 21 indexed citations
5.
Fan, Yao‐Yue, Hong‐Chun Liu, Cheng‐Hui Xu, et al.. (2020). Crokonoids A–C, A Highly Rearranged and Dual-Bridged Spiro Diterpenoid and Two Other Diterpenoids from Croton kongensis. Organic Letters. 22(3). 929–933. 25 indexed citations
6.
Wang, Xinyi, Jing Ai, Hongyan Liu, et al.. (2018). The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. Molecular Cancer Therapeutics. 18(3). 667–679. 11 indexed citations
7.
Dai, Xiaoyang, Juan Yan, Xuhong Fu, et al.. (2017). Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase. Clinical Cancer Research. 23(20). 6267–6278. 98 indexed citations
8.
Ai, Jing, Yi Chen, Peng Xia, et al.. (2017). Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. Molecular Cancer Therapeutics. 17(4). 751–762. 26 indexed citations
9.
Liu, Hongyan, Jing Ai, Aijun Shen, et al.. (2016). c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors. Clinical Cancer Research. 23(4). 974–984. 28 indexed citations
10.
Sun, Wenyi, Zuoquan Xie, Yifu Liu, et al.. (2015). JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification. Cancer Research. 75(22). 4923–4936. 69 indexed citations
11.
Shen, Aijun, Lu Wang, Min Huang, et al.. (2015). c-Myc Alterations Confer Therapeutic Response and Acquired Resistance to c-Met Inhibitors in MET-Addicted Cancers. Cancer Research. 75(21). 4548–4559. 37 indexed citations
12.
Jiang, Xiaolong, Ji Zhou, Jing Ai, et al.. (2015). Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study. European Journal of Medicinal Chemistry. 105. 39–56. 15 indexed citations
13.
Wang, Wei, Ying-Qing Wang, Tao Meng, et al.. (2014). MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189. Molecular Cancer Therapeutics. 13(6). 1480–1491. 29 indexed citations
14.
Manzo, Stefano Giustino, Zhaoli Zhou, Ying-Qing Wang, et al.. (2012). Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II. Cancer Research. 72(20). 5363–5373. 94 indexed citations
15.
Xie, Hua, Mee‐Hyun Lee, Feng Zhu, et al.. (2012). Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform. Cancer Research. 73(2). 716–724. 26 indexed citations
16.
Yu, Bing, Ze‐Hong Miao, Yi Jiang, et al.. (2009). c-Jun Protects Hypoxia-Inducible Factor-1α from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner. Cancer Research. 69(19). 7704–7712. 42 indexed citations
17.
Huang, Min, Ze‐Hong Miao, Hong Zhu, et al.. (2008). Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. Molecular Cancer Therapeutics. 7(6). 1440–1449. 62 indexed citations
18.
Li, Haihong, Jinzhi Tan, Lili Chen, et al.. (2007). Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives. Acta Pharmacologica Sinica. 28(1). 140–152. 14 indexed citations
19.
Tan, Jinzhi, Hong Liu, Xiaomin Luo, et al.. (2007). Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives. Acta Pharmacologica Sinica. 28(1). 140–152. 2 indexed citations
20.
Zhao, Huajun, Haiying Liu, Yi Chen, et al.. (2006). Oligomannurarate Sulfate, a Novel Heparanase Inhibitor Simultaneously Targeting Basic Fibroblast Growth Factor, Combats Tumor Angiogenesis and Metastasis. Cancer Research. 66(17). 8779–8787. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muthu K. Shanmugam Breakdown of academic impact, for papers by Stefan Laufer Breakdown of academic impact, for papers by Aamir Ahmad Breakdown of academic impact, for papers by Qidong You Breakdown of academic impact, for papers by Guang Liang Breakdown of academic impact, for papers by Meiyu Geng Breakdown of academic impact, for papers by Qiaojun He Breakdown of academic impact, for papers by Jin‐Jian Lu Breakdown of academic impact, for papers by Sanjeev Banerjee Breakdown of academic impact, for papers by Róbert Kiss
Rankless by CCL
2026